LU84853A1 - Facteurs 1,2,3,4 et 5 individuels purs de la teichomycine a2 et leur procede de preparation - Google Patents

Facteurs 1,2,3,4 et 5 individuels purs de la teichomycine a2 et leur procede de preparation Download PDF

Info

Publication number
LU84853A1
LU84853A1 LU84853A LU84853A LU84853A1 LU 84853 A1 LU84853 A1 LU 84853A1 LU 84853 A LU84853 A LU 84853A LU 84853 A LU84853 A LU 84853A LU 84853 A1 LU84853 A1 LU 84853A1
Authority
LU
Luxembourg
Prior art keywords
factor
nujol
solution
acetonitrile
teichomycin
Prior art date
Application number
LU84853A
Other languages
English (en)
French (fr)
Inventor
Angelo Borghi
Giovanni Cassani
Rosa Pallanza
Carolina Coronelli
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of LU84853A1 publication Critical patent/LU84853A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
LU84853A 1982-06-08 1983-06-08 Facteurs 1,2,3,4 et 5 individuels purs de la teichomycine a2 et leur procede de preparation LU84853A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08
GB8216590 1982-06-08

Publications (1)

Publication Number Publication Date
LU84853A1 true LU84853A1 (fr) 1984-03-07

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84853A LU84853A1 (fr) 1982-06-08 1983-06-08 Facteurs 1,2,3,4 et 5 individuels purs de la teichomycine a2 et leur procede de preparation

Country Status (32)

Country Link
US (1) US4542018A (el)
JP (5) JPS591423A (el)
KR (1) KR900008246B1 (el)
AU (1) AU560966B2 (el)
BE (1) BE896993A (el)
BG (1) BG60529B2 (el)
CA (1) CA1208204A (el)
CH (1) CH657139A5 (el)
DE (1) DE3320342A1 (el)
DK (1) DK159117C (el)
ES (2) ES8503689A1 (el)
FI (1) FI73697C (el)
FR (1) FR2528050B1 (el)
GB (1) GB2121401B (el)
GR (1) GR78267B (el)
HK (1) HK55887A (el)
HU (1) HU193538B (el)
IE (1) IE55025B1 (el)
IL (1) IL68819A0 (el)
IT (1) IT1212085B (el)
LU (1) LU84853A1 (el)
MY (1) MY8700002A (el)
NL (1) NL8301980A (el)
NO (1) NO159104C (el)
NZ (1) NZ204480A (el)
PH (1) PH19533A (el)
PT (1) PT76831B (el)
SE (1) SE459094B (el)
SG (1) SG70686G (el)
SU (1) SU1318170A3 (el)
UA (1) UA6025A1 (el)
ZA (1) ZA833607B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
EP0560795B1 (en) * 1990-12-05 1996-02-21 GRUPPO LEPETIT S.p.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US6218505B1 (en) 1996-04-23 2001-04-17 Biosearch Italia S.P.A. Chemical process for preparing amide derivatives of antibiotic A 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20050130909A1 (en) * 2002-11-18 2005-06-16 Luigi Colombo Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
NZ204480A (en) 1986-04-11
BG60529B2 (bg) 1995-07-28
GB8315003D0 (en) 1983-07-06
FI73697B (fi) 1987-07-31
IE831329L (en) 1983-12-08
PT76831A (en) 1983-07-01
BE896993A (fr) 1983-12-07
DK245883A (da) 1983-12-09
DE3320342A1 (de) 1983-12-08
NO159104B (no) 1988-08-22
ZA833607B (en) 1984-03-28
CA1208204A (en) 1986-07-22
SE8303211D0 (sv) 1983-06-07
FR2528050B1 (fr) 1987-03-20
JPH02291279A (ja) 1990-12-03
AU1496883A (en) 1983-12-15
JPH0224278B2 (el) 1990-05-29
NO159104C (no) 1988-11-30
HU193538B (en) 1987-10-28
DK159117C (da) 1991-02-11
SE459094B (sv) 1989-06-05
JPH0415237B2 (el) 1992-03-17
IL68819A0 (en) 1983-09-30
KR900008246B1 (ko) 1990-11-06
PT76831B (en) 1986-04-09
JPH0517237B2 (el) 1993-03-08
DK245883D0 (da) 1983-05-31
JPS591423A (ja) 1984-01-06
ES536770A0 (es) 1985-08-16
DE3320342C2 (el) 1991-07-11
GB2121401B (en) 1985-09-18
JPH02291278A (ja) 1990-12-03
FI831660A0 (fi) 1983-05-12
KR840005170A (ko) 1984-11-05
IT8321432A0 (it) 1983-06-02
AU560966B2 (en) 1987-04-30
ES8506748A1 (es) 1985-08-16
NO831754L (no) 1983-12-09
NL8301980A (nl) 1984-01-02
US4542018A (en) 1985-09-17
MY8700002A (en) 1987-12-31
SE8303211L (sv) 1983-12-09
JPH02288887A (ja) 1990-11-28
PH19533A (en) 1986-05-20
FI831660L (fi) 1983-12-09
HK55887A (en) 1987-08-07
SG70686G (en) 1987-07-03
GB2121401A (en) 1983-12-21
ES522941A0 (es) 1985-04-01
FR2528050A1 (fr) 1983-12-09
JPH02288888A (ja) 1990-11-28
ES8503689A1 (es) 1985-04-01
JPH0415238B2 (el) 1992-03-17
UA6025A1 (uk) 1994-12-29
JPH0517236B2 (el) 1993-03-08
GR78267B (el) 1984-09-26
FI73697C (fi) 1987-11-09
DK159117B (da) 1990-09-03
CH657139A5 (fr) 1986-08-15
SU1318170A3 (ru) 1987-06-15

Similar Documents

Publication Publication Date Title
LU84853A1 (fr) Facteurs 1,2,3,4 et 5 individuels purs de la teichomycine a2 et leur procede de preparation
HU194317B (en) Process for production of a 40926 antibioticum-complex and its clean components, pa, pb,a,b and b under o factor and medical compounds containing thereof
DE602004005203T2 (de) Antibiotikum 107891, dessen Faktoren A1 und A2, pharmazeutisch annehmbare Salzeund Zusammensetzungen und Verwendung davon
JP3107584B2 (ja) 抗生物質ｇｅ２２７０因子ｂ１、ｂ２、ｃ１、ｃ２、ｄ１、ｄ２、ｅおよびｔ
CA1340338C (en) Glycopeptide antibiotic pa-45052 and the production thereof
HU179463B (en) Process for preparing deoxy-narasin antibiotic complex
JPH029381A (ja) 抗生物質
JP2002544138A (ja) Ａｃｒｅｍｏｎｉｕｍｔｕｂａｋｉｉ由来の新規抗寄生虫薬であるセファイボール、その製造方法およびその使用
DE2833689C2 (el)
US4226879A (en) Antibiotic composition
DE2652677C2 (de) Antibiotica 890A↓1↓ und 890A↓3↓, Verfahren zu ihrer Herstellung und diese Antibiotika enthaltende antibakterielle Mittel
DE3136675A1 (de) Neues peptid und dessen herstellung
HU204893B (en) Process for producing polyether antibiotics and pharmaceutical compositions comprising same
CA1052308A (fr) Substance anticoccidienne 30.504 rp de streptomyces gallinarius
DE3003359C2 (el)
US4137224A (en) Process for the preparation of antibiotic W-10 complex and for the isolation of antibiotic 20561 and antibiotic 20562 therefrom
JPH07114704B2 (ja) 抗生物質ａ４２８６７およびその付加塩
JPH01240196A (ja) 新規グリコペプチド系抗生物質ｐａ−４５０５２
JPS6111206B2 (el)
CH623566A5 (en) Process for producing the new depsipeptide antibiotics neoviridogrisein I, II, III
JPS60199397A (ja) グリコペプチド系抗生物質およびその製造方法
CH637137A5 (en) Antibiotic and process for its preparation
JP2535045B2 (ja) ハロサイアミンおよびその製造法
BE830043A (fr) Antibiotique a-28086 et procede de production
JPH0449277A (ja) 新規物質ｃｃ１２

Legal Events

Date Code Title Description
TA Annual fee